Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume

References

• Møller S, Henriksen JH. Neurohumoral fluid regulation in chronic liver disease. Scand J Clin Lab Invest 1998; 58: 361–72
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Møller S, Ring-Larsen H, Christensen NJ. The sympathetic nervous system in liver disease. J Hepatol 1998; 29: 328–41
   PubMed Web of Science ®Google Scholar
• Bernardi M, Trevisani F, Caraceni P. The renin-angiotensin-aldosterone system in cirrhosis. Ascites and renal dysfunction in liver disease, V Arroyo, P Gines, J Rodes, RW Schrier. Blackwell Science, Massachusetts 1999; 175–97
   Google Scholar
• Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, et al. Hepatic hemodynamics and renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 1980; 78: 92–9
   PubMed Web of Science ®Google Scholar
• Aliaga L, Zozoya JM, Omar M, Mediavilla JD, Prieto J. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis. Acta Gastroenterol Belg 1995; 58: 213–21
   PubMedGoogle Scholar
• Salo J, Francitorra A, Follo A, Navasa M, Gines A, Jimenez W, et al. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume. J Hepatol 1995; 22: 389–98
   PubMedGoogle Scholar
• Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403–9
   PubMed Web of Science ®Google Scholar
• Brinch K, Møller S, Bendtsen F, Becker U, Henriksen JH. Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. J Hepatol 2003; 39: 24–31
   PubMed Web of Science ®Google Scholar
• Salerno F, Cazzaniga M, Pagnozzi G, Cirello I, Nicolini A, Meregaglia D, et al. Humoral and cardiac effects of TIPS in cirrhotic patients with different “effective” blood volume. Hepatology 2003; 38: 1370–7
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects. Semin Nephrol 1997; 17: 505–19
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 5: 1151–7
   Web of Science ®Google Scholar
• Schrier RW, Ecder T. Unifying hypothesis of body fluid volume regulation: implications for cardiac failure and cirrhosis. Mt Sinai J Med 2001; 68: 350–61
   PubMedGoogle Scholar
• Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol ;38 Suppl 2003; 1: S69–89
   Google Scholar
• Schrier RW, Gurevich AK, Cadnapaphornchai MA. Pathogenesis and management of sodium and water retention in cardiac failure and cirrhosis. Semin Nephrol 2001; 21: 157–72
   PubMedGoogle Scholar
• Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989; 97: 1506–13
   PubMed Web of Science ®Google Scholar
• Møller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109: 1917–25
   PubMed Web of Science ®Google Scholar
• Gluud, C, and The Copenhagen Study Group for Liver Diseases. Serum testosterone concentration in men with alcoholic cirrhosis: background for variation. Metabolism 1987;36:373–8.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Winkler W. Hepatic blood flow determination. A comparison of 99-Tc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987; 4: 66–70
   PubMed Web of Science ®Google Scholar
• Lassen NA, Henriksen O, Sejrsen P. Indicator method for measurement of organ and tissue blood flow. Handbook of physiology: the cardiovascular system III. Munksgaard, Copenhagen 1984; 21–63
   Google Scholar
• Colombato LA, Albillos A, Groszmann J. The role of central blood volume in the development of sodium retention in portal hypertensive rats. Gastroenterology 1996; 110: 193–8
   PubMed Web of Science ®Google Scholar
• Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646–54
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH, Bendtsen F. Central- and non-central blood volumes in cirrhosis. Relation to anthropometrics and gender. Am J Physiol Gastrointest Liver Physiol 2003; 284: G970–9
   PubMed Web of Science ®Google Scholar
• Michell AR. Effective blood volume: an effective concept or a modern myth. Perspect Biol Med 1996; 39: 471–90
   PubMedGoogle Scholar
• Møller S, Nørgaard A, Henriksen JH, Frandsen E, Bendtsen F. Effects of tilting on central hemodynamics and homeostatic mechanisms in cirrhosis. Hepatology 2004; 40: 811–9
   PubMed Web of Science ®Google Scholar
• Salo J, Gines A, Anibarro L, Jimenez W, Bataller R, Claria J, et al. Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels. Hepatology 1995; 22: 479–87
   PubMed Web of Science ®Google Scholar
• Nicholls KM, Shapiro MD, Kluge R. Sodium excretion in advanced cirrhosis: effect of expansion of central blood volume and suppression of plasma aldosterone. Hepatology 1986; 82: 709–19
   Google Scholar
• Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, et al. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites. Eur J Clin Invest 1979; 1: 69–73
   Google Scholar
• Møller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001; 61: 421–9
   PubMed Web of Science ®Google Scholar
• Møller S, Gülberg V, Henriksen JH, Gerbes AL. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics. J Hepatol 1995; 23: 135–44
   PubMed Web of Science ®Google Scholar
• Bernardi M, Gülberg V, Colantoni A, Trevisani F, Gasbarrini A, Gerbes AL. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. J Hepatol 1996; 24: 161–8
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. Pathogenesis and pathophysiology of hepatorenal syndrome: is there scope for prevention?. Aliment Pharmacol Ther ;20 Suppl 2004; 3: 31–41
   Google Scholar
• Jalan R, Hayes PC. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut 2000; 46: 527–33
   PubMedGoogle Scholar
• Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999; 29: 334–9
   PubMed Web of Science ®Google Scholar
• De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, et al. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol 2003; 98: 1371–6
   PubMed Web of Science ®Google Scholar